Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Nexalin Technology's profit margin for the twelve months ending Jun 30, 2026 was -4139.4%. For fiscal 2025 it was -2725.8%, against -4508.7% the year before. The highest annual figure on record is -128.5% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2725.8% | +1783.0 |
| FY2024 | Dec 31, 2024 | -4508.7% | −311.2 |
| FY2023 | Dec 31, 2023 | -4197.6% | −4069.1 |
| FY2022 | Dec 31, 2022 | -128.5% | +4090.4 |
| FY2021 | Dec 31, 2021 | -4218.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -18412.7% | −16173.0 |
| Q1 FY2026 | Mar 31, 2026 | -14025.7% | −9177.8 |
| Q4 FY2025 | Dec 31, 2025 | -1382.6% | +9041.9 |
| Q3 FY2025 | Sep 30, 2025 | -12542.3% | −5747.5 |
| Q2 FY2025 | Jun 30, 2025 | -2239.7% | +2546.0 |
| Q1 FY2025 | Mar 31, 2025 | -4847.8% | −3524.4 |
| Q4 FY2024 | Dec 31, 2024 | -10424.5% | −8110.4 |
| Q3 FY2024 | Sep 30, 2024 | -6794.9% | −4345.9 |
| Q2 FY2024 | Jun 30, 2024 | -4785.7% | −2886.7 |
| Q1 FY2024 | Mar 31, 2024 | -1323.4% | −1298.6 |
| Q2 FY2023 | Jun 30, 2023 | -2314.1% | −2208.0 |
| Q1 FY2023 | Mar 31, 2023 | -2449.0% | −2327.4 |
| Q4 FY2022 | Dec 31, 2022 | -1899.0% | +584.1 |
| Q3 FY2022 | Sep 30, 2022 | -24.8% | +3190.7 |
| Q2 FY2022 | Jun 30, 2022 | -106.1% | – |
| Q1 FY2022 | Mar 31, 2022 | -121.6% | – |
| Q4 FY2021 | Dec 31, 2021 | -2483.1% | – |
| Q3 FY2021 | Sep 30, 2021 | -3215.5% | – |
See a number that looks wrong?